Auflistung nach Autor "Bethge, Wolfgang Andreas"

Anzeige der Dokumente 1-20 von 104

Nächste Seite

A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy

Bethge, Wolfgang Andreas (2020)
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

Bethge, Wolfgang Andreas (2014)
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study

Bethge, Wolfgang Andreas (2019)
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation : a multicentre, randomised, phase 3 trial

Bethge, Wolfgang Andreas (2019)
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Opherk, Kathrin; Lang, Peter; Kayser, Simone; Hartl, Lena; Handgretinger, Rupert; Feuchtinger, Tobias; Feucht, Judith; Bethge, Wolfgang Andreas (2015)
Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1-Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation

Icheva, Vanya Dimitrova; Kayser, Simone; Kyzirakos, Christina; Bethge, Wolfgang Andreas; Schumm, Michael; Stevanović, Stefan; Handgretinger, Rupert; Lang, Peter; Feuchtinger, Tobias (2013)
Allogene hämatopoetische Stammzelltransplantation. Eine Option bei Autoimmunerkrankungen?

Wirths, Stefan; Bethge, Wolfgang Andreas; Henes, Jörg Christoph (2016)
Allogeneic haematopoietic cell transplantation offers the chance of cure for patients with transformed follicular lymphoma

Müller, Annerose; Bethge, Wolfgang Andreas; Heinzelmann, Frank Michael (2018)
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Heinzelmann, Frank Michael; Bethge, Wolfgang Andreas; Müller, Annerose (2016)
Allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia and pulmonary mucormycosis

Schneidawind, Dominik; Faul, Christoph; Vogel, Wichard; Kanz, Lothar; Bethge, Wolfgang Andreas; Horger, Marius Stefan; Nann, Dominik; Fend, Falko (2012)
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

Bethge, Wolfgang Andreas (2021)
Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience

Schmohl, Jörg Uwe; Faul, Christoph; Vogel, Wichard; Möhle, Robert; Wirths, Stefan; Schneidawind, Dominik; Kanz, Lothar; Bethge, Wolfgang Andreas (2016)
Allogeneic hematopoietic cell transplantation in patients ⩾70 years : which patients may benefit?

Haen, Sebastian P.; Pham, M.; Faul, Christoph; Dörfel, Daniela; Vogel, Wichard; Kanz, Lothar; Bethge, Wolfgang Andreas (2016)
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies improved outcomes over two decades

Bethge, Wolfgang Andreas (2021)
Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia

Schneidawind, Dominik; Federmann, Birgit; Faul, Christoph; Vogel, Wichard; Kanz, Lothar; Bethge, Wolfgang Andreas (2013)
Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)

Bethge, Wolfgang Andreas (2015)
Allogeneic Stem Cell Transplantation for Patients Age >= 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT

Bethge, Wolfgang Andreas (2017)
Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation

Kanz, Lothar; Bethge, Wolfgang Andreas; Schmohl, Jörg Uwe; Bethge, Wolfgang Andreas (2016)
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease

Bethge, Wolfgang Andreas (2016)
Augmented FLAMSA-Bu versus FluBu2 reduced-intensity conditioning in patients with active relapsed/refractory acute myeloid leukemia: an EBMT analysis

Bethge, Wolfgang Andreas (2022)

Anzeige der Dokumente 1-20 von 104

Nächste Seite

Veröffentlichen

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Einloggen

Auflistung nach Autor "Bethge, Wolfgang Andreas"

Auflistung nach Autor "Bethge, Wolfgang Andreas"

Stöbern

Gesamter Bestand

Mein Benutzerkonto

Hilfe & Infos